版本:
中国

BRIEF-Juniper Pharmaceuticals Q4 EPS $0.88

March 7 Juniper Pharmaceuticals Inc

* Juniper pharmaceuticals reports fourth quarter and full-year 2016 financial and operating results

* Q4 earnings per share $0.88

* Q4 revenue rose 143 percent to $20.9 million

* Juniper pharmaceuticals inc - expect to continue ind-enabling activities which could potentially support three ind filings in first half of 2018

* Juniper pharmaceuticals inc- "operating expense will increase modestly year over year" in 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐